/Investor DB

Viking Global Investors — 2015 Investments

4 investments dated 2015 · listed companies and verified rows first · show all

Ginkgo Bioworksginkgo.bioin𝕏NYSE: DNAJul 2015

Ginkgo Bioworks designs custom engineered organisms for customers across multiple markets, operating foundries that use software and hardware automation to scale the organism engineering process.

Advanced ManufacturingAgTechAI & Machine LearningBiotechDeep TechHealthtechRoboticsBoston, US

Jason Kelly(Founder)inReshma Shetty(Founder)inBarry Canton(Founder)inAustin Che(Founder)inTom Knight(Founder)inBartholomew Canton(Executive Officer)

Co-investors11.2 CapitalAllen Institute for AI (AI2) IncubatorAzure Capital PartnersB3 HoldingBlue Owl CapitalCannage Capital+62 more

AlphaSensealpha-sense.comin𝕏Aug 2015

AlphaSense provides a financial research and market intelligence platform that combines standardized financials, consensus estimates, filings, earnings transcripts, broker research, and AI-generated answers for analyzing and benchmarking companies.

AI & Machine LearningData & InfrastructureEnterprise SoftwareFintechNew York, US

Rajmohan Neervannan(Related person at the time of the offering.)Raj Neervannan(Founder)inJaakko (Jack) Kokko(Founder)inJack Kokko(Founder)inKiva Kolstein(President & Chief Revenue Officer)inHeather Zynczak(Chief Marketing Officer)in

Co-investorsAlkeon InnovationBlue Owl CapitalBond Capital ManagementBrama One VenturesCapitalGCentana Growth Partners+12 more

Credit Karmacreditkarma.comin𝕏Jun 2015 · $175MAcquired

Credit Karma is an AI-powered personal finance platform that provides free credit scores, credit monitoring, cashflow insights, and financial marketplace services to help consumers understand and manage their finances.

AI & Machine LearningConsumerFintechSan Francisco, US

Kenneth Lin(Founder)inNichole Mustard(Founder)inRyan Graciano(Founder)inKen Lin(Founder)

Co-investors500 GlobalArcher Capital GroupArcher Venture CapitalCapitalGEQUIAMFelicis Ventures+11 more

EpiBiomeepibiome.comOct 2015

BiotechSouth San Francisco, US

Aaron Tynes Hammack(Executive Officer, Director)Nicholas Conley(Executive Officer, Director)

BoardPing-Chuan Tsai(Director)

Co-investorsStartXAlexandriaMatrix Capital ManagementSv Tech Ventures, Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.